About Decipher Labs Ltd 
Decipher Labs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Decipher Labs Limited was initially incorporated as Combat Drugs Private Limited, as a Private Limited Company in September, 1986. It was converted into a Public Limited Company and the name of the Company was changed to Combat Drugs Limited in June 1992. Subsequently, the name of the Company was changed to Decipher Labs Limited dated 12 February, 2020.
Company Coordinates 
Company Details
4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2 Hyderabad Telangana : 500034
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Capital Structure 
Present Equity Capital
INR 10.10 Cr
Number of Shares
1.01 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
19-Dec-2019
1.01
10.10
2100000
10
Preferential basis
19-Dec-2019
1.01
10.10
2100000
10
Preferential basis
01-Oct-2011
8
8.00
7676860
10
Scheme of Arrangement
30-Sep-2011
8
8.00
7676860
10
Scheme of Arrangement
19-Sep-2011
32.31
0.32
0
1
Capital Reduction
19-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
18-Sep-2011
32.31
0.32
0
1
Capital Reduction
18-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Ajjarapu Janakiram (16.43%)
Highest Public shareholder
None
Individual Investors Holdings
78.48%
Management
Designation
Remuneration
Sushant Mohan Lal
Executive Director
3.0 lacs
G Venkateswara Rao
Independent Director
0
Megha Agarwal
Company Sec. & Compli. Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Material purchased
0.6725
0%
Material purchased
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharma Goods - Tablets, Liquids & Capsules
0.50
100.00%
Pharma Goods - Tablets, Liquids & Capsules
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Dec 2025)
Net Profit:
-1 Cr
Pharmaceuticals & Biotechnology
INR 8 Cr (Micro Cap)
NA (Loss Making)
32
0.00%
-0.02
-42.37%
0.40






